What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings

Zacks
Open on Zacks
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings

Wall Street analysts expect Cigna (CI) to post quarterly earnings of $7.46 per share in its upcoming report, which indicates a year-over-year decline of 4.7%. Revenues are expected to be $73.53 billion, up 5.7% from the year-ago quarter.

Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

With that in mind, let's delve into the average projections of some Cigna metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts expect 'Revenues- Evernorth Health Services' to come in at $64.06 billion. The estimate suggests a change of +6.1% year over year.

It is projected by analysts that the 'Revenues- Cigna Healthcare' will reach $11.65 billion. The estimate indicates a change of +6.6% from the prior-year quarter.

The consensus among analysts is that 'Revenues- Cigna Healthcare- Premiums- U.S. Commercial - Stop loss' will reach $2.18 billion. The estimate suggests a change of +14.1% year over year.

The collective assessment of analysts points to an estimated 'Revenues- Cigna Healthcare- Premiums- U.S. Commercial - Employer insured' of $4.99 billion. The estimate suggests a change of +6.1% year over year.

The consensus estimate for 'Medical Care Ratio - Cigna Healthcare' stands at 85.1%. The estimate compares to the year-ago value of 84.8%.

Based on the collective assessment of analysts, 'Medical Customers - U.S. Healthcare' should arrive at 16.75 million. The estimate compares to the year-ago value of 16.35 million.

Analysts' assessment points toward 'Covered Lives By Market Segment - Medical Customers - International Health' reaching 1.62 million. Compared to the present estimate, the company reported 1.71 million in the same quarter last year.

According to the collective judgment of analysts, 'Medical Customers - Total' should come in at 18.37 million. Compared to the present estimate, the company reported 18.06 million in the same quarter last year.

The combined assessment of analysts suggests that 'Healthcare Medical Customers - Administrative services only - U.S. Healthcare' will likely reach 14.20 million. Compared to the current estimate, the company reported 13.79 million in the same quarter of the previous year.

The average prediction of analysts places 'Healthcare Medical Customers - Insured - U.S. Healthcare' at 2.47 million. Compared to the present estimate, the company reported 2.56 million in the same quarter last year.

Analysts forecast 'Pharmacy claim volume' to reach 553.94 million. The estimate is in contrast to the year-ago figure of 558.00 million.

Analysts predict that the 'Healthcare Medical Customers - Administrative services only - Total' will reach 14.66 million. Compared to the current estimate, the company reported 14.23 million in the same quarter of the previous year.

View all Key Company Metrics for Cigna here>>>

Shares of Cigna have demonstrated returns of +10.2% over the past month compared to the Zacks S&P 500 composite's -0.9% change. With a Zacks Rank #3 (Hold), CI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Cigna Group (CI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research